Electrophoresis Market Size & Growth Forecast 2027–2036, By Segments (Application, End Use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Electrophoresis Market size was valued at USD 3.6 billion in 2026 and is anticipated to grow at a 5.34% CAGR from 2027 to 2036, exceeding USD 6.06 billion by 2036. The industry revenue for 2027 is assessed at USD 3.76 billion.

• Base Year Value (2026): USD 3.6 billion
• CAGR (2027-2036): 5.34%
• Forecast Year Value (2036): USD 6.06 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Electrophoresis Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America holds 37.53% share, driven by strong life sciences research infrastructure, widespread laboratory usage, and consistent demand for consumables in molecular analysis workflows.
  • Asia Pacific is expanding at 6.44% CAGR due to rising lab capacity, growing biotech research activity, and wider adoption of molecular testing techniques.

• Segment Momentum:

  • Research Applications held a 55.28% share in 2026, driven by routine use of electrophoresis for protein, nucleic acid, and molecular separation in laboratories where reliable analytical workflows are essential.
  • Pharmaceutical and Biotechnology Companies are the fastest-growing end users as expanding drug research, biologics development, quality assessment, and molecular analysis continue to increase reliance on electrophoresis across core laboratory operations.

• Market Expansion Drivers:

  • Growing precision medicine and genetic research increasing demand for biomolecule separation technologies.
  • Adoption of automated high-throughput electrophoresis systems improving laboratory efficiency and reproducibility.
  • Rising biologics and gene therapy development strengthening protein characterization requirements.

• Leading Market Participants:

  Leading players in the electrophoresis market include Thermo Fisher Scientific Inc. (United States), Bio-Rad Laboratories, Inc. (United States), Agilent Technologies, Inc. (United States), Merck KGaA (Germany), Cytiva (United States), QIAGEN N.V. (Netherlands), Danaher Corporation (United States), Shimadzu Corporation (Japan), Lonza Group Ltd. (Switzerland), Harvard Bioscience, Inc. (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 3.6 billion
  • 2027 Estimated Market Size: USD 3.76 billion.
  • Projected Market Size: USD 6.06 billion by 2036
  • Growth Forecasts: 5.34% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Research Applications (Application) | Pharmaceutical and Biotechnology Companies (End Use) | Electrophoresis Reagents (Product)
  • Emerging Opportunity Segment: Research Applications (Application) | Pharmaceutical and Biotechnology Companies (End Use) | Electrophoresis Systems (Product)

Market Growth Drivers and Industry Trends

Growing precision medicine and genetic research increasing demand for biomolecule separation technologies

The expansion of precision medicine and genetic research is increasing the need to separate, identify, and analyze DNA, RNA, proteins, and other biomolecules, which will drive the electrophoresis market growth. Researchers and clinical laboratories rely on electrophoretic techniques to examine molecular characteristics and evaluate biological samples during genomic and proteomic investigations. As research becomes increasingly focused on understanding individual molecular profiles and disease mechanisms, dependable separation and analysis capabilities remain important across diagnostic, pharmaceutical, and research applications.

Adoption of automated high-throughput electrophoresis systems improving laboratory efficiency and reproducibility

Laboratories are increasingly adopting automated electrophoresis platforms to streamline sample processing and reduce variability associated with manual procedures, supporting electrophoresis market growth. Automated systems can improve workflow consistency by standardizing sample preparation, separation, detection, and result handling, while high-throughput capabilities allow laboratories to process larger volumes of samples efficiently. These improvements are particularly useful in research and diagnostic environments where reproducible results, faster turnaround, and efficient utilization of laboratory resources are essential.

Rising biologics and gene therapy development strengthening protein characterization requirements

The expanding development of biologic medicines and gene-based therapies is increasing the importance of detailed molecular characterization, creating additional demand within the electrophoresis market. Protein separation and analysis are essential for evaluating product composition, purity, structural characteristics, and manufacturing consistency during biopharmaceutical development. As developers work with increasingly complex biological products, electrophoretic methods provide laboratories with analytical capabilities for assessing biomolecules throughout research, development, and quality-control processes.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Growing precision medicine and genetic research increasing demand for biomolecule separation technologies	2.10%	High	North America, Europe	High	Near Term
Adoption of automated high-throughput electrophoresis systems improving laboratory efficiency and reproducibility	1.80%	Moderate	North America, Asia Pacific	High	Mid Term
Rising biologics and gene therapy development strengthening protein characterization requirements	1.50%	High	North America, Europe, Asia Pacific	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

The electrophoresis market was led by North America, which held a 37.53% share in 2026. The region’s strong position is linked to extensive biomedical research, advanced laboratory infrastructure, and widespread use of electrophoresis across genomics, proteomics, molecular diagnostics, and pharmaceutical research. Well-established research institutions and clinical laboratories are supporting continued demand for analytical techniques used to separate and characterize proteins and nucleic acids. Increasing emphasis on precision medicine and molecular-level disease research is also expanding applications in clinical and life science settings. In parallel, investments in biotechnology and laboratory modernization are encouraging the adoption of sophisticated electrophoresis systems and consumables.

Asia Pacific is projected to be the fastest-growing regional market, driven by expanding biotechnology research, increasing healthcare investment, and the modernization of laboratory facilities. Growing pharmaceutical and life science activity is creating broader applications for electrophoresis in research, quality control, molecular diagnostics, and drug development. The region’s expanding scientific infrastructure is also enabling more laboratories to adopt advanced analytical technologies. In addition, rising research activity in genomics and proteomics, coupled with increasing demand for sophisticated diagnostic capabilities, is strengthening the need for reliable separation and analysis techniques and supporting wider adoption of electrophoresis technologies.

Key Country Insights

United States

Research Workflow Expansion

The U.S. maintains strong demand for electrophoresis systems across life science research, molecular diagnostics, and pharmaceutical development. Laboratories in the U.S. continue prioritizing automation, reproducibility, and higher sample throughput to improve analytical efficiency.

Japan

Analytical Efficiency Focus

Japan supports adoption of electrophoresis technologies that improve laboratory productivity while maintaining high analytical accuracy. Academic and industrial laboratories in Japan increasingly integrate digital documentation and automated sample processing into routine workflows.

South Korea

Biotechnology Research Support

South Korea continues expanding electrophoresis use across biotechnology research, genomics, and clinical laboratory environments. Demand in South Korea reflects growing interest in efficient analytical platforms that complement advanced molecular research activities.

Germany

Laboratory Precision Standards

Germany emphasizes highly reliable electrophoresis platforms that support pharmaceutical quality control and biomedical research. Research institutions in Germany continue investing in systems that deliver consistent analytical performance across routine laboratory applications.

France

Clinical Laboratory Integration

France strengthens electrophoresis adoption across hospital laboratories and biomedical research centers supporting molecular testing. Laboratories in France increasingly seek systems that simplify workflow management while maintaining dependable analytical performance.

Italy

Academic Research Demand

Italy supports steady electrophoresis adoption through university research programs, biomedical laboratories, and diagnostic facilities. Research organizations in Italy continue upgrading laboratory infrastructure to improve analytical consistency and operational efficiency.

Segment Leadership and Growth Trends

 

Application Segment Analysis: Research Applications (Largest & Fastest-Growing Segment)

Research applications held the largest share and represented the fastest-growing segment of the electrophoresis market in 2026, accounting for 55.28% of the market. Electrophoresis remains a fundamental analytical technique across molecular biology, genomics, proteomics, and biochemical research because it enables reliable separation and characterization of nucleic acids and proteins. Growing research activity in life sciences, increasing use of molecular analysis in drug discovery, and continued advances in electrophoretic techniques are strengthening demand from research laboratories. The expanding focus on precision analysis and biomolecular characterization further supports the segment's sustained importance.

End Use Segment Analysis: Pharmaceutical and Biotechnology Companies (Largest & Fastest-Growing Segment)

Pharmaceutical and biotechnology companies dominated the electrophoresis market in 2026 and also represented its fastest-growing end-use segment, with a 46.33% share. Electrophoresis is extensively integrated into drug discovery, biomolecule characterization, quality assessment, and biopharmaceutical development workflows, creating consistent demand from these organizations. Increasing investment in biologics, molecular research, and advanced therapeutic development is expanding the need for analytical techniques that provide accurate separation and identification of biological components. The growing complexity of pharmaceutical research and quality-control requirements is further reinforcing electrophoresis adoption across industry laboratories.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Application	Research Applications, Diagnostics Applications, Quality Control and Process Validation	Research Applications	Research Applications
End Use	Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Centers, Others	Pharmaceutical and Biotechnology Companies	Pharmaceutical and Biotechnology Companies
Product	Electrophoresis Reagents, Electrophoresis Systems, Gel Documentation Systems, Software	Electrophoresis Reagents	Electrophoresis Systems

Competitive Landscape and Market Positioning

Key companies in the electrophoresis market:

1. Thermo Fisher Scientific Inc. (United States)

2. Bio-Rad Laboratories Inc. (United States)

3. Agilent Technologies Inc. (United States)

4. Merck KGaA (Germany)

5. Cytiva (United States)

6. QIAGEN N.V. (Netherlands)

7. Danaher Corporation (United States)

8. Shimadzu Corporation (Japan)

9. Lonza Group Ltd. (Switzerland)

10. Harvard Bioscience Inc. (United States)

The electrophoresis market is witnessing sustained innovation driven by increasing demand for accurate biomolecular analysis across research, diagnostics, and pharmaceutical applications. Manufacturers are introducing advanced systems with automated sample handling, improved resolution capabilities, and digital data integration features. Expanding applications in genomics, proteomics, and forensic science continue to strengthen competitive developments within the market.

Industry Development/News

Company Name	Date	Key Development
LICORbio	Jul-25	LICORbio finalized the acquisition of Serva Electrophoresis, aimed at diversifying its analytical protein separation portfolio. This strategic consolidation strengthens the company’s competitive positioning in the life sciences and biopharmaceutical sectors by integrating specialized electrophoresis technologies and service capabilities into its existing infrastructure.
Cytiva and Veeda Lifesciences	Nov-25	Cytiva and Veeda Lifesciences established a specialized Host Cell Protein (HCP) Services Center in Bengaluru. This facility bolsters analytical support for biologics manufacturing by optimizing protein characterization workflows, directly enhancing technical capabilities for electrophoresis-based bioanalytical processes critical to quality control and process development in the biopharmaceutical industry.
Sysmex Corporation and Hitachi High-Tech Corporation	Feb-24	Sysmex Corporation and Hitachi High-Tech Corporation formed a strategic partnership to co-develop advanced genetic testing systems. The collaboration focuses on leveraging capillary electrophoresis sequencing technology, reflecting a concerted effort to integrate complementary technical expertise for the development of high-throughput molecular diagnostic solutions within the global clinical and research market.
Agilent Technologies Inc.	Jan-24	Agilent Technologies launched the ProteoAnalyzer system, an automated parallel capillary electrophoresis platform. The system is engineered to streamline the analysis of complex protein mixtures, addressing critical operational bottlenecks in pharmaceutical, biotechnology, and food analysis sectors by improving the efficiency and precision of routine protein characterization workflows.